Biotech news for Thursday, July 2, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
ismagilov Stock futures pointed lower on Thursday, putting Wall Street on track to end the holiday-shortened week on a softer note ahead of America's 250th Independence Day. Investor sentiment remained cautious ahead of the closely watched June jobs report and…
Alvotech ( ALVO ) announced an amendment to its existing credit agreement , securing a new term loan facility of up to $75M. The financing was led by long-term partner GoldenTree Asset Management LP alongside other existing lenders. This debt facility builds u…
IMUNON ( IMNN ) announced a transition in its financial leadership. Jeffrey Church has retired from his role as interim CFO, effective July 1, 2026. He is succeeded by seasoned life sciences financial executive Josh Blacher, who will serve as the company’s new
Sixth Street Partners and KKR & Co. ( KKR ) have reportedly agreed to provide $1B of preferred equity to biotechnology company BridgeBio Pharma ( BBIO ). The financing, expected to be announced as soon as Wednesday, will help BridgeBio accelerate the launc…
Abivax SA ( ABVX ) on Tuesday announced the launch of an underwritten public offering of ~$600M of its American Depositary Shares, each representing one ordinary share of Abivax, nominal value €0.01 per share. Abivax also expects to grant the underwriters of t…
Neurogene ( NGNE ) commenced a public offering of common stock, with certain investors able to purchase pre-funded warrants instead of shares. The company expects to grant underwriters a 30-day option to purchase additional shares. All securities are being off…
AbbVie ( ABBV ) shares snapped six straight sessions of gains on Tuesday, as the stock was 1.3% lower at $251.13. The biopharmaceutical company gained 10.6% in the preceding six sessions. ABBV climbed over 6% alone after the company agreed to acquire